These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7533268)

  • 1. Follow-up study of patients with "unilateral" moyamoya disease.
    Kawano T; Fukui M; Hashimoto N; Yonekawa Y
    Neurol Med Chir (Tokyo); 1994 Nov; 34(11):744-7. PubMed ID: 7533268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Endothelial Shear Stress on the Bilateral Progression of Unilateral Moyamoya Disease.
    Lee WJ; Jeong SK; Han KS; Lee SH; Ryu YJ; Sohn CH; Jung KH
    Stroke; 2020 Mar; 51(3):775-783. PubMed ID: 31856692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance angiography demonstrating adult moyamoya disease progressing from unilateral to bilateral involvement--case report.
    Kagawa R; Okada Y; Moritake K; Takamura M
    Neurol Med Chir (Tokyo); 2004 Apr; 44(4):183-6. PubMed ID: 15185756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of adult moyamoya disease showing fulminant clinical course associated with progression from unilateral to bilateral involvement].
    Fujiwara F; Yamada H; Hayashi S; Tamaki N
    No Shinkei Geka; 1997 Jan; 25(1):79-84. PubMed ID: 8990473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide survey on quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up study of patients with unilateral moyamoya disease.
    Hirotsune N; Meguro T; Kawada S; Nakashima H; Ohmoto T
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S178-81. PubMed ID: 9409432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical features of disease progression in adult moyamoya disease.
    Kuroda S; Ishikawa T; Houkin K; Nanba R; Hokari M; Iwasaki Y
    Stroke; 2005 Oct; 36(10):2148-53. PubMed ID: 16179571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of disease in unilateral moyamoya syndrome.
    Smith ER; Scott RM
    Neurosurg Focus; 2008; 24(2):E17. PubMed ID: 18275294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The usefulness of MRI and MR angiography in the diagnosis of Moyamoya disease in children].
    Belkhribchia MR; El Moutawakil B; Bennis A; Abdo Rafai M; Slassi I
    Presse Med; 2014 Nov; 43(11):1287-90. PubMed ID: 25027462
    [No Abstract]   [Full Text] [Related]  

  • 10. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.
    Fukui M
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S238-40. PubMed ID: 9409446
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions.
    Narisawa A; Fujimura M; Tominaga T
    Clin Neurol Neurosurg; 2009 Feb; 111(2):123-6. PubMed ID: 18995956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is "unilateral" moyamoya disease different from moyamoya disease?
    Houkin K; Abe H; Yoshimoto T; Takahashi A
    J Neurosurg; 1996 Nov; 85(5):772-6. PubMed ID: 8893713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The main epidemiological, clinical and morphological features of moyamoya disease in Yugoslavia.
    Borota L; Bajic R; Marinkovic S; Maksimovic R; Markovic Z; Kovacevic M
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S49-53. PubMed ID: 9409405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult onset moyamoya disease: institutional experience.
    Chinchure SD; Pendharkar HS; Gupta AK; Bodhey N; Harsha KJ
    Neurol India; 2011; 59(5):733-8. PubMed ID: 22019660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moyamoya disease: an elusive diagnosis.
    Asumal KB; Akhtar N; Syed NA; Shafqat S; Baig SM
    J Pak Med Assoc; 2003 Apr; 53(4):160-2. PubMed ID: 12776902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Atherosclerotic Obliteration Of Bilateral Supraclinoid Internal Carotid Arteries; A Classic Case Of Moyamoya Disease.
    Ullah S; Siddiqui AA; Alkilani WZ; Jang Khan NA; Siddiqui HU
    J Ayub Med Coll Abbottabad; 2017; 29(2):363-365. PubMed ID: 28718269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical prognosis and therapeutic aspects in management of pediatric moyamoya disease].
    Tamogami R; Oi S; Nonaka Y; Miwa T; Abe T
    Nihon Rinsho; 2010 Jan; 68(1):45-52. PubMed ID: 20077789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.